Changes in Psychological Outcomes after Cessation of Full Mu Agonist Long-Term Opioid Therapy for Chronic Pain

Improved understanding of psychological features associated with full mu agonist long-term opioid therapy (LTOT) cessation may offer advantages for clinicians. This preliminary study presents changes in psychological outcomes in patients with chronic, non-cancer pain (CNCP) after LTOT cessation via...

Full description

Bibliographic Details
Main Authors: Marcelina Jasmine Silva, Zhanette Coffee, Chong Ho Alex Yu, Joshua Hu
Format: Article
Language:English
Published: MDPI AG 2023-02-01
Series:Journal of Clinical Medicine
Subjects:
Online Access:https://www.mdpi.com/2077-0383/12/4/1354
_version_ 1797620209039704064
author Marcelina Jasmine Silva
Zhanette Coffee
Chong Ho Alex Yu
Joshua Hu
author_facet Marcelina Jasmine Silva
Zhanette Coffee
Chong Ho Alex Yu
Joshua Hu
author_sort Marcelina Jasmine Silva
collection DOAJ
description Improved understanding of psychological features associated with full mu agonist long-term opioid therapy (LTOT) cessation may offer advantages for clinicians. This preliminary study presents changes in psychological outcomes in patients with chronic, non-cancer pain (CNCP) after LTOT cessation via a 10-week multidisciplinary program which included treatment with buprenorphine. Paired <i>t</i>-tests pre- and post-LTOT cessation were compared in this retrospective cohort review of data from electronic medical records of 98 patients who successfully ceased LTOT between the dates of October 2017 to December 2019. Indicators of quality of life, depression, catastrophizing, and fear avoidance, as measured by the 36-Item Short Form Survey, the Patient Health Questionnaire-9-Item Scale, the Pain Catastrophizing Scale, and the Fear Avoidance Belief Questionnaires revealed significant improvement. Scores did not significantly improve for daytime sleepiness, generalized anxiety, and kinesiophobia, as measured by the Epworth Sleepiness Scale, the Generalized Anxiety Disorder 7-Item Scale, and the Tampa Scale of Kinesiophobia. The results suggest that successful LTOT cessation may be interconnected with improvements in specific psychological states.
first_indexed 2024-03-11T08:38:53Z
format Article
id doaj.art-9bbf7ccde78541f0847543b93a173a08
institution Directory Open Access Journal
issn 2077-0383
language English
last_indexed 2024-03-11T08:38:53Z
publishDate 2023-02-01
publisher MDPI AG
record_format Article
series Journal of Clinical Medicine
spelling doaj.art-9bbf7ccde78541f0847543b93a173a082023-11-16T21:18:22ZengMDPI AGJournal of Clinical Medicine2077-03832023-02-01124135410.3390/jcm12041354Changes in Psychological Outcomes after Cessation of Full Mu Agonist Long-Term Opioid Therapy for Chronic PainMarcelina Jasmine Silva0Zhanette Coffee1Chong Ho Alex Yu2Joshua Hu3The Focus on Opioid Transitions (FOOT Steps) Program, IPM Medical Group, Walnut Creek, CA 94598, USACollege of Nursing, University of Arizona, Tucson, AZ 85721, USAOffice of Institutional Research, Azusa Pacific University, Azusa, CA 91702, USACollege of Osteopathic Medicine, Touro University, Vallejo, CA 94592, USAImproved understanding of psychological features associated with full mu agonist long-term opioid therapy (LTOT) cessation may offer advantages for clinicians. This preliminary study presents changes in psychological outcomes in patients with chronic, non-cancer pain (CNCP) after LTOT cessation via a 10-week multidisciplinary program which included treatment with buprenorphine. Paired <i>t</i>-tests pre- and post-LTOT cessation were compared in this retrospective cohort review of data from electronic medical records of 98 patients who successfully ceased LTOT between the dates of October 2017 to December 2019. Indicators of quality of life, depression, catastrophizing, and fear avoidance, as measured by the 36-Item Short Form Survey, the Patient Health Questionnaire-9-Item Scale, the Pain Catastrophizing Scale, and the Fear Avoidance Belief Questionnaires revealed significant improvement. Scores did not significantly improve for daytime sleepiness, generalized anxiety, and kinesiophobia, as measured by the Epworth Sleepiness Scale, the Generalized Anxiety Disorder 7-Item Scale, and the Tampa Scale of Kinesiophobia. The results suggest that successful LTOT cessation may be interconnected with improvements in specific psychological states.https://www.mdpi.com/2077-0383/12/4/1354chronic painopioidspatient experiencespsychological outcomesmanagementtreatment
spellingShingle Marcelina Jasmine Silva
Zhanette Coffee
Chong Ho Alex Yu
Joshua Hu
Changes in Psychological Outcomes after Cessation of Full Mu Agonist Long-Term Opioid Therapy for Chronic Pain
Journal of Clinical Medicine
chronic pain
opioids
patient experiences
psychological outcomes
management
treatment
title Changes in Psychological Outcomes after Cessation of Full Mu Agonist Long-Term Opioid Therapy for Chronic Pain
title_full Changes in Psychological Outcomes after Cessation of Full Mu Agonist Long-Term Opioid Therapy for Chronic Pain
title_fullStr Changes in Psychological Outcomes after Cessation of Full Mu Agonist Long-Term Opioid Therapy for Chronic Pain
title_full_unstemmed Changes in Psychological Outcomes after Cessation of Full Mu Agonist Long-Term Opioid Therapy for Chronic Pain
title_short Changes in Psychological Outcomes after Cessation of Full Mu Agonist Long-Term Opioid Therapy for Chronic Pain
title_sort changes in psychological outcomes after cessation of full mu agonist long term opioid therapy for chronic pain
topic chronic pain
opioids
patient experiences
psychological outcomes
management
treatment
url https://www.mdpi.com/2077-0383/12/4/1354
work_keys_str_mv AT marcelinajasminesilva changesinpsychologicaloutcomesaftercessationoffullmuagonistlongtermopioidtherapyforchronicpain
AT zhanettecoffee changesinpsychologicaloutcomesaftercessationoffullmuagonistlongtermopioidtherapyforchronicpain
AT chonghoalexyu changesinpsychologicaloutcomesaftercessationoffullmuagonistlongtermopioidtherapyforchronicpain
AT joshuahu changesinpsychologicaloutcomesaftercessationoffullmuagonistlongtermopioidtherapyforchronicpain